SPOTLIGHT -
Dr. Kimmick on Selecting Adjuvant Therapy for Patients With HER2+ Breast Cancer
Gretchen G. Kimmick, MD, MS, discusses selecting adjuvant therapy for patients with HER2-positive breast cancer.
Read More
Dr. Kimmick on the Evolving HER2+ Breast Cancer Treatment Paradigm
Gretchen G. Kimmick, MD, MS, discusses the quickly evolving treatment paradigm for patients with HER2-positive breast cancer.
Dr. Kimmick on the Results of the ATEMPT Trial in Early-Stage HER2+ Breast Cancer
Gretchen G. Kimmick, MD, MS, discusses the results of the phase 2 ATEMPT trial in early-stage HER2-positive breast cancer
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
